REMINE

According to recent studies, Risks Against Patient Safety (RAPS) represent one of the most important factors of dead in hospitals: during therapy, more then 8% of patients recovered in hospitals suffer for additional disease that in almost 50% of the cases produce either dead or significant additional health problems. RAPS occur in any stage of the patient care process.

REMINE project idea originates from the common difficulty in conducting a analysis, early identification and effective prevention on RAP when there are significant mass of inhomogeneous data sources, stored in multimedia databases, and a distributed environments with different care professionals contemporary involved.

To contrast the RAPS trends and the malpractices diffusion, REMINE prosecutes a number of main objectives. a new technological platform, new care process organizational requirements. Main elements are: mining of multimedia data; modelling, prediction, detection of RAPS, RAPS management support system and info broker patient safety framework.

Main outcomes of REMINE will be: time reduction in collecting data, time reduction in RAPS analysis, standardization of common language, evolution in the interaction model, reference framework, patient safety improvement, health care cost saving (within an estimated RAPS reduction between 6% to 9% of RAPS.

For further information, please visit:
http://www.remine-project.eu

Project co-ordinator:
GMD - Gesellschaft für Medizinische Datenverarbeitung mbH

Partners:

  • INFO WORLD S.R.L. (Romania)
  • CONSORZIO PER L'INNOVAZIONE NELLA GESTIONE DELLE IMPRESE E DELLA PUBBLICA AMMINISTRAZIONE DENOMINATO ANCHE MIP (Italy)
  • The Rotherham Foundation Trust (United Kingdom)
  • Research in Advanced Medical Informatics and Telematics (Belgium)
  • Technische Universität Wien (Austria)
  • SEK-Suupohjan elinkeinotoimen kuntayhtymä (Finland)
  • SOLUZIONA, S.A. (Slovenia)
  • The Institute of Communications and Computer Systems (Greece)
  • QUALITY AND SYSTEMS CONSULTING LTD (United Kingdom)
  • QUALITY & RELIABILITY A.E. (Greece)
  • Aminio AB (Sweden)
  • Link Consulting - Tecnologias de Informacao S.A. (Portugal)
  • Hewlett-Packard Italiana Srl (Italy)
  • Regione Lombardia (Italy)

Timetable: from 01/2008 - to 12/2010

Total cost: € 7.728.249

EC funding: € 5.400.000

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)


Related news article:

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...